Back to search
FDAFDA · Food and drugs·Recall number D-720-2013

Dexpanthenol 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Published July 17, 2013 · Recall initiated: May 29, 2013

Summary

FDA records drug Class II recall D-720-2013, published July 17, 2013 and initiated May 29, 2013. Recalling firm: Lowlite Investments, Inc. D/B/A Olympia Pharmacy; Status: Ongoing; Reported quantity: 1; Lot: I5406 Exp 9/30/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Distributor
Nationwide and PR
Lot
I5406 Exp 9/30/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dexpanthenol 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL recalled?

Yes. FDA published recall D-720-2013 on July 17, 2013. Reported hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit